NA
ABMD

NewEdge Advisors’s Abiomed Inc ABMD Stock Holding History

NewEdge Advisors’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,483
Closed -$365K – 4271
2022
Q3 		$365K Buy
1,483
+366
+33% +$98.8K 0.01% 1103
2022
Q2 		$276K Buy
+1,117
New +$301K ﹤0.01% 1251
2019
Q2 		– Sell
-1,225
Closed -$350K – 711
2019
Q1 		$350K Sell
1,225
-647
-35% -$215K 0.02% 486
2018
Q4 		$608 Buy
1,872
+595
+47% +$207K 0.04% 328
2018
Q3 		$574K Buy
+1,277
New +$503K 0.04% 327

Other funds holding ABMD

TRSOTSOK
Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
AW
Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

NewEdge Advisors's ABMD Position: Q4 2022 in Review

NewEdge Advisors sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 1,483 shares — an estimated $365K sold.

NewEdge Advisors first reported a position in ABMD in Q3 2018 and held it in 5 quarters. The position peaked at $574K in Q3 2018. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • NewEdge Advisors reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • NewEdge Advisors sold 1,483 Abiomed Inc shares in Q4 2022, an estimated $365K.
  • NewEdge Advisors first reported a position in Abiomed Inc in Q3 2018 and held it in 5 quarters.
  • NewEdge Advisors's Abiomed Inc position peaked at $574K in Q3 2018.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on NewEdge Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.